Xie, J., Li, Y., Jiang, K., Hu, K., Zhang, S., Dong, X., . . . Xu, S. (2018). CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer. Theranostics.
Παραπομπή Chicago StyleXie, Jie, et al. "CDK16 Phosphorylates and Degrades P53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer." Theranostics 2018.
Παραπομπή MLAXie, Jie, et al. "CDK16 Phosphorylates and Degrades P53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer." Theranostics 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.